Avacta Group Plc (AVCT):企業の財務・戦略的SWOT分析

◆英語タイトル:Avacta Group Plc (AVCT) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME16609FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Avacta Group Plc (Avacta) is a developer therapeutic molecules used in a wide range of life sciences applications in research and diagnostics. The company offers products that include optim and sensipod. It also develops UCB celltech that is an analytical instrument. Avacta’s sensipod is an in-clinical blood testing system that delivers ELISA tests. The company offers intellectual property relating to an alternative to antibodies. It develops reagents and diagnostics that are used in affinity chromatography, protein to protein interactions, immunoassay and rapid diagnostic test applications, among others. It has operations in Wetherby, Cambridge and London. Avacta is headquartered in Wetherby, the UK.

Avacta Group Plc Key Recent Developments

Apr 06,2021: Avacta Group: Distribution Agreement with ABCAM
Apr 06,2021: Avacta: Distribution agreement with ABCAM
Mar 25,2021: Avacta Group announces Director change
Feb 24,2021: Avacta Group: Significant momentum in both Diagnostics and Therapeutics Divisions
Jan 29,2021: Avacta and Bruker collaborate to evaluate SARS-CoV-2 assay

This comprehensive SWOT profile of Avacta Group Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Avacta Group Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Avacta Group Plc – Key Information
Avacta Group Plc – Overview
Avacta Group Plc – Key Employees
Avacta Group Plc – Key Employee Biographies
Avacta Group Plc – Key Operational Heads
Avacta Group Plc – Major Products and Services
Avacta Group Plc – History
Avacta Group Plc – Company Statement
Avacta Group Plc – Locations And Subsidiaries
Avacta Group Plc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Avacta Group Plc – Business Description
Avacta Group Plc – Corporate Strategy
Avacta Group Plc – SWOT Analysis
SWOT Analysis – Overview
Avacta Group Plc – Strengths
Avacta Group Plc – Weaknesses
Avacta Group Plc – Opportunities
Avacta Group Plc – Threats
Avacta Group Plc – Key Competitors

Section 3 – Company Financial Performance Charts

Avacta Group Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Avacta Group Plc, Key Information
Avacta Group Plc, Key Ratios
Avacta Group Plc, Share Data
Avacta Group Plc, Major Products and Services
Avacta Group Plc, History
Avacta Group Plc, Key Employees
Avacta Group Plc, Key Employee Biographies
Avacta Group Plc, Key Operational Heads
Avacta Group Plc, Other Locations
Avacta Group Plc, Subsidiaries
Avacta Group Plc, Key Competitors
Avacta Group Plc, SWOT Analysis
Avacta Group Plc, Ratios based on current share price
Avacta Group Plc, Annual Ratios
Avacta Group Plc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Avacta Group Plc (AVCT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Exillon Energy Plc (EXI):企業の財務・戦略的SWOT分析
    Summary Exillon Energy Plc (Exillon) is an oil exploration and production company. The company explores, produces and develops crude oil. Its services include drilling, exploration, appraisal, development, operations, management, and production services. Exillon’s operating assets are located in two …
  • RFIB Group Limited:企業の戦略・SWOT・財務情報
    RFIB Group Limited - Strategy, SWOT and Corporate Finance Report Summary RFIB Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • ImmunoGen Inc (IMGN)-医療機器分野:企業M&A・提携分析
    Summary ImmunoGen Inc (ImmunoGen) is a biotechnology company that carries out the development of anticancer therapeutics. The company uses its proprietary antibody-drug conjugates (ADC) technology for the development of the products. It develops products for the treatment of various types of cancer …
  • CECO Environmental Corp (CECE):企業の財務・戦略的SWOT分析
    CECO Environmental Corp (CECE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Nando’s Chickenland Limited:企業の戦略的SWOT分析
    Nando's Chickenland Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Dana Brevini SpA:企業の戦略・SWOT・財務情報
    Dana Brevini SpA - Strategy, SWOT and Corporate Finance Report Summary Dana Brevini SpA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Murmanskoye Morskoye Parokhodstvo:企業の戦略・SWOT・財務分析
    Murmanskoye Morskoye Parokhodstvo - Strategy, SWOT and Corporate Finance Report Summary Murmanskoye Morskoye Parokhodstvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • SoftBank Group Corporation:企業のM&A・事業提携・投資動向
    SoftBank Group Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's SoftBank Group Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • ERHC Energy Inc (ERHE):企業の財務・戦略的SWOT分析
    Summary ERHC Energy Inc (ERHC Energy) is an exploration and production company that explores oil and gas assets. The company possesses deep water oil and gas exploration and production interests in the Gulf of Guinea and onshore interests in Republic of Chad and Republic of Kenya. It holds interests …
  • Co-Diagnostics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Co-Diagnostics Inc (Co-Diagnostics) is a molecular diagnostics company that develops, manufactures and markets a state-of-the-art diagnostics technology. The company’s products include HCV RNA real-time PCR kit, HIV RNA real-time PCR kit, malaria DNA real-time PCR kit, and TB complex DNA kit …
  • RainDance Technologies Inc-製薬・医療分野:企業M&A・提携分析
    Summary RainDance Technologies Inc (RDT) is a developer of genomic tools for non-invasive liquid biopsy applications. The company’s products include RainDrop Plus, a digital PCR system that provides picoliter droplets for multiplex detection of HIV and DNA. It also offers RainDrop Plus digital PCR s …
  • TMX Group Ltd (X):企業の財務・戦略的SWOT分析
    TMX Group Ltd (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • True Diagnostics Inc:企業の製品パイプライン分析2018
    Summary True Diagnostics Inc (True Diagnostics) is a research, development and manufacturing company that offers in-vitro immunodiagnostic test systems and reagents. The company provides diagnostics such as self testing, point of care testing and companion diagnostics. It offers trueDX platform tech …
  • Stellar Biotechnologies Inc (SBOT)-製薬・医療分野:企業M&A・提携分析
    Summary Stellar Biotechnologies Inc (Stellar Bio), formerly CAG Capital Inc is a provider of keyhole limpet hemocyanin proteins. The company offers potent immune-stimulating molecule used as an active pharmaceutical ingredient known as active immunotherapies or therapeutic vaccines and as an injecta …
  • Molinos Rio de la Plata SA (MOLI3):企業の財務・戦略的SWOT分析
    Molinos Rio de la Plata SA (MOLI3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Korea Research Institute of Bioscience and Biotechnology:製薬・医療:M&Aディール及び事業提携情報
    Summary Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute which provides bioinformatic services. The institute operates in the fields of strategic research, biomedical sciences, system biology and bioengineering, business development, and bioinfrastr …
  • Chegg, Inc.:企業のM&A・事業提携・投資動向
    Chegg, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Chegg, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Union des Groupements d’Achats Publics:企業の戦略的SWOT分析
    Union des Groupements d'Achats Publics - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Hetero Drugs Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Hetero Drugs Ltd (Hetero) is a manufacturer of active pharmaceutical ingredients, intermediate chemicals and finished dosages. The company specializes in process chemistry, API manufacturing, formulation development, manufacturing and commercialization of bio-generics, and also offers custom …
  • Luye Pharma Group Ltd (2186):企業の財務・戦略的SWOT分析
    Summary Luye Pharma Group Ltd (Luye Pharma Group) is a drug company that manufactures, develops, discovers, and commercializes novel formulations, natural drugs, medicinal products, pharmaceutical products, and biotechnology products. The group’s products include paclitaxel liposome, lentinan, sodiu …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆